About the Company
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SRTS News
Sensus Healthcare (SRTS) Price Target Increased by 24.07% to 6.83
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and ...
Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.17 per share a year ago.
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customersActive ...
Sensus Healthcare to Participate in the 36th Annual Roth Conference
BOCA RATON, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost ...
Analysts Offer Insights on Healthcare Companies: Vigil Neuroscience Inc (VIGL) and Daxor (DXR)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vigil Neuroscience Inc (VIGL – Research ...
Sensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Shareholders will be ecstatic, with their stake up 23% over the past week following Sensus Healthcare, Inc.'s (NASDAQ:SRTS) latest annual results. It was overall a positive result, with revenues ...
Sensus Healthcare Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.17 per share a year ago.
Sensus Healthcare Inc SRTS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Sensus Healthcare Inc SRTS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
SRTS Sensus Healthcare, Inc.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Loading the latest forecasts...